Post COVID-19 AA amyloidosis of the kidneys with rapidly progressive renal failure

Prion. 2023 Dec;17(1):111-115. doi: 10.1080/19336896.2023.2201151.

Abstract

Coronavirus disease 2019 (COVID-19) pandemic has taken the world by a storm, posing a gruelling challenge to the medical fraternity globally. Besides its very high infectivityinfectivity, significant organ dysfunction occurs in critically ill COVID-19 patients, leading to severe morbidity and mortality. Pulmonary involvement is the leading cause of death in these patients to be followed by the cardiovascular involvement. Kidney involvement due to COVID-19 is becoming more discernible with AKI adversely affecting the outcome. Besides AKI, a few cases of collapsing FSGS in genetically vulnerable patients and thrombotic microangiopathies have been reported as well. We report a case of AA amyloidosis of the kidney with a rapidly progressive renal failure and congestive heart failure with preserved left ventricular functions, which complicated a moderate COVID-19 pneumonia providing some clues to a possible association of this novel virus disease with this complication, which needs to be confirmed in future studies.

Keywords: AA- Amyloidosis; COVID-19; Prion-like domains in SARS-CoV-2 spike protein; rapidly progressive renal failure: segment SK-9 of SARS CoV-2; renal AA amyloidosis.

Publication types

  • Case Reports

MeSH terms

  • Acute Kidney Injury* / etiology
  • COVID-19* / complications
  • Humans
  • Kidney
  • SARS-CoV-2

Supplementary concepts

  • AA amyloidosis

Grants and funding

The author(s) reported that there is no funding associated with the work featured in this article.